Online:
Visits:
Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

VolitionRx to present at the 29th annual ROTH Conference

Wednesday, March 8, 2017 13:25
% of readers think this story is Fact. Add your two cents.

(Before It's News)

VolitionRx Limited (NYSEMKT:VNRX) said on Wednesday it will present at the 29th Annual ROTH Conference being held March 12-15 in Dana Point, California.

Scott Powell, Executive Vice President of Volition, will provide an update on Volition’s business, clinical, regulatory and operational milestones, as well as the Company’s recently announced product launch of its Nu.QTM Colorectal Cancer Screening Triage Test.

Read: VolitionRX kicks off Nu.Q colorectal cancer screening test in Denmark Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/174490/volitionrx-to-present-at-the-29th-annual-roth-conference-174490.html

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.